Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001214659-25-000922
Filing Date
2025-01-17
Accepted
2025-01-17 16:49:21
Documents
155

Document Format Files

Seq Description Document Type Size
1 i114255f1.htm   iXBRL F-1 4912661
2 EXHIBIT 4.1 ex4_1.htm EX-4.1 350313
3 EXHIBIT 5.1 ex5_1.htm EX-5.1 73312
4 EXHIBIT 21.1 ex21_1.htm EX-21.1 4710
5 EXHIBIT 23.1 ex23_1.htm EX-23.1 4686
6 FILING FEE IXBRL exfilingfees.htm EX-FILING FEES 12891
12 GRAPHIC biodexa_logo.jpg GRAPHIC 13595
13 GRAPHIC forvismazars_logo.jpg GRAPHIC 16691
14 GRAPHIC pipeline_chart.jpg GRAPHIC 125185
  Complete submission text file 0001214659-25-000922.txt   19610597

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE bdrx-20240630.xsd EX-101.SCH 142536
8 XBRL CALCULATION FILE bdrx-20240630_cal.xml EX-101.CAL 86172
9 XBRL DEFINITION FILE bdrx-20240630_def.xml EX-101.DEF 334971
10 XBRL LABEL FILE bdrx-20240630_lab.xml EX-101.LAB 539214
11 XBRL PRESENTATION FILE bdrx-20240630_pre.xml EX-101.PRE 528257
157 EXTRACTED XBRL INSTANCE DOCUMENT i114255f1_htm.xml XML 4527572
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-284350 | Film No.: 25539294
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)